D.E. Shaw & Co’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.43M | Buy |
+992,825
| New | +$2.43M | ﹤0.01% | 1808 |
|
2023
Q3 | – | Sell |
-42,215
| Closed | -$839K | – | 3224 |
|
2023
Q2 | $839K | Sell |
42,215
-43,530
| -51% | -$865K | ﹤0.01% | 2152 |
|
2023
Q1 | $1.47M | Sell |
85,745
-96,417
| -53% | -$1.65M | ﹤0.01% | 2003 |
|
2022
Q4 | $3.56M | Sell |
182,162
-266,180
| -59% | -$5.21M | ﹤0.01% | 1664 |
|
2022
Q3 | $7.16M | Buy |
448,342
+260,041
| +138% | +$4.15M | 0.01% | 1156 |
|
2022
Q2 | $2.59M | Sell |
188,301
-3,211
| -2% | -$44.2K | ﹤0.01% | 2086 |
|
2022
Q1 | $3.04M | Buy |
191,512
+40,018
| +26% | +$635K | ﹤0.01% | 2109 |
|
2021
Q4 | $3.31M | Sell |
151,494
-33,940
| -18% | -$741K | ﹤0.01% | 2020 |
|
2021
Q3 | $5.54M | Sell |
185,434
-14,584
| -7% | -$436K | 0.01% | 1397 |
|
2021
Q2 | $8.86M | Sell |
200,018
-106,232
| -35% | -$4.71M | 0.01% | 1124 |
|
2021
Q1 | $13.6M | Sell |
306,250
-12,388
| -4% | -$550K | 0.01% | 870 |
|
2020
Q4 | $17.5M | Buy |
318,638
+98,759
| +45% | +$5.42M | 0.02% | 742 |
|
2020
Q3 | $5.03M | Sell |
219,879
-6,323
| -3% | -$145K | 0.01% | 1187 |
|
2020
Q2 | $4.73M | Buy |
226,202
+18,799
| +9% | +$393K | 0.01% | 1190 |
|
2020
Q1 | $2.89M | Buy |
207,403
+188,976
| +1,026% | +$2.64M | ﹤0.01% | 1333 |
|
2019
Q4 | $419K | Buy |
+18,427
| New | +$419K | ﹤0.01% | 2254 |
|
2019
Q1 | – | Sell |
-11,166
| Closed | -$165K | – | 2697 |
|
2018
Q4 | $165K | Sell |
11,166
-13,890
| -55% | -$205K | ﹤0.01% | 2412 |
|
2018
Q3 | $617K | Sell |
25,056
-32,694
| -57% | -$805K | ﹤0.01% | 2006 |
|
2018
Q2 | $1.13M | Sell |
57,750
-81,450
| -59% | -$1.6M | ﹤0.01% | 1849 |
|
2018
Q1 | $2.61M | Buy |
139,200
+14,127
| +11% | +$265K | ﹤0.01% | 1383 |
|
2017
Q4 | $1.31M | Buy |
125,073
+90,042
| +257% | +$940K | ﹤0.01% | 1723 |
|
2017
Q3 | $249K | Buy |
35,031
+14,340
| +69% | +$102K | ﹤0.01% | 2283 |
|
2017
Q2 | $157K | Sell |
20,691
-3,782
| -15% | -$28.7K | ﹤0.01% | 2289 |
|
2017
Q1 | $196K | Sell |
24,473
-1,384
| -5% | -$11.1K | ﹤0.01% | 2289 |
|
2016
Q4 | $631K | Sell |
25,857
-24,799
| -49% | -$605K | ﹤0.01% | 1937 |
|
2016
Q3 | $1.92M | Buy |
50,656
+14,969
| +42% | +$568K | ﹤0.01% | 1403 |
|
2016
Q2 | $1.06M | Buy |
35,687
+27,476
| +335% | +$818K | ﹤0.01% | 1761 |
|
2016
Q1 | $243K | Buy |
8,211
+4,550
| +124% | +$135K | ﹤0.01% | 2324 |
|
2015
Q4 | $166K | Buy |
+3,661
| New | +$166K | ﹤0.01% | 2472 |
|